Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar